Mayo Clinic, GE Healthcare, GMI and breast cancer
Remember Mayo Clinic working with GE Healthcare and Gamma Medica-Ideas on molecular breast imaging to spot super small breast cancer tumors?
In 2006, Mayo and the two medical companies researched using dual-head gamma cameras for breast imaging.
While GE is frequent dance partner with Mayo Clinic, Mayo apparently choose Gamma Medica-Ideas ov er GE Healthcare in 2009 and signed "…An exclusive license and commericalization agreement with Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists, headed by Michael O'Connor."
The focus at that ti me was on GMI's LumaGem imaging system, pulled in $24 million in venture funding in Sept. 2009.
Now GE Healthcare is running clinical trials on its own molecular breast imaging or MBI system.
A release came out to day announcing "…its collaboration in two clinical trials with the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel and Hamilton Health Sciences Hospital in Ontario, Canada." GE is referencing Mayo as a predictor of future positive results.
This quote is from today's release from GE: "Extensive early clinical work done in the Mayo Clinic in the U.S. shows encouraging results with the use of MBI technology."
All of this adds up to interesting moves in the very competitive breast cancer market.